[HTML][HTML] Changes of the cytokine profile in inflammatory bowel diseases
G Műzes, B Molnár, Z Tulassay… - World journal of …, 2012 - ncbi.nlm.nih.gov
Cytokines are indispensable signals of the mucosa-associated immune system for
maintaining normal gut homeostasis. An imbalance of their profile in favour of inflammation …
maintaining normal gut homeostasis. An imbalance of their profile in favour of inflammation …
Mouse models of inflammatory bowel disease
S Wirtz, MF Neurath - Advanced drug delivery reviews, 2007 - Elsevier
Animal models of intestinal inflammation are indispensable for our understanding of the
pathogenesis of Crohn disease and Ulcerative colitis, the idiopathic forms of inflammatory …
pathogenesis of Crohn disease and Ulcerative colitis, the idiopathic forms of inflammatory …
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
WJ Sandborn, BG Feagan, RN Fedorak, E Scherl… - Gastroenterology, 2008 - Elsevier
Background & Aims: Interleukin-12 and interleukin-23 are inflammatory cytokines implicated
in Crohn's disease pathophysiology. Ustekinumab is a monoclonal antibody against the p40 …
in Crohn's disease pathophysiology. Ustekinumab is a monoclonal antibody against the p40 …
[HTML][HTML] Recent advances: the imbalance of cytokines in the pathogenesis of inflammatory bowel disease
Q Guan, J Zhang - Mediators of inflammation, 2017 - hindawi.com
Cytokines play an important role in the immunopathogenesis of inflammatory bowel disease
(IBD), including Crohn's disease and ulcerative colitis, where they drive and regulate …
(IBD), including Crohn's disease and ulcerative colitis, where they drive and regulate …
Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort
Background Ustekinumab is a monoclonal antibody targeting interleukins‐12 and‐23, with
efficacy in Crohn's disease (CD) demonstrated in clinical trials. Aim To assess the real‐world …
efficacy in Crohn's disease (CD) demonstrated in clinical trials. Aim To assess the real‐world …
Ustekinumab for the treatment of refractory Crohn's disease: the Spanish experience in a large multicentre open-label cohort
S Khorrami, D Ginard, I Marín-Jiménez… - Inflammatory bowel …, 2016 - academic.oup.com
Background Ustekinumab is a fully human monoclonal antibody against IL-12/23.
Ustekinumab induced clinical response and maintained higher rate of response than …
Ustekinumab induced clinical response and maintained higher rate of response than …
The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence
RG Maunder, S Levenstein - Current molecular medicine, 2008 - ingentaconnect.com
Background: It is unclear whether psychological stress contributes to the inflammatory
process in the inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn's …
process in the inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn's …
[HTML][HTML] Selected biomarkers of depression: what are the effects of cytokines and inflammation?
S Harsanyi, I Kupcova, L Danisovic, M Klein - International journal of …, 2022 - mdpi.com
Depression is one of the leading mental illnesses worldwide and lowers the quality of life of
many. According to WHO, about 5% of the worldwide population suffers from depression …
many. According to WHO, about 5% of the worldwide population suffers from depression …
[PDF][PDF] Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study
CJ Lessard, I Adrianto, JA Ice, GB Wiley… - The American Journal of …, 2012 - cell.com
Systemic lupus erythematosus (SLE) is a chronic heterogeneous autoimmune disorder
characterized by the loss of tolerance to self-antigens and dysregulated interferon …
characterized by the loss of tolerance to self-antigens and dysregulated interferon …
[HTML][HTML] 溃疡性结肠炎发病机制研究进展
桑力轩, 刘汉立, 姜敏 - 世界华人消化杂志, 2007 - wjgnet.com
尽管对溃疡性结肠炎的临床研究有100 多年的历史, 但是他的真正病因尚不清楚,
多种因素可能促进这种疾病的发生和发展. 环境因素可能影响遗传易感性, 遗传易感性与异常的 …
多种因素可能促进这种疾病的发生和发展. 环境因素可能影响遗传易感性, 遗传易感性与异常的 …